PW Consulting: PFIC2 Market USD 250.71M in 2025, 19.34% CAGR to USD 870.16M by 2032
Worldwide Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC2) Treatment Market: Strategic Outlook for 2026 — A PW Consulting Industry Brief
As the therapeutic landscape for Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC2) accelerates from orphan-niche to a commercially actionable segment, executive teams face a compressed window to translate clinical advances into...